UNSPSC 51362506: Zopiclone

This classification denotes a sedative and hypnotic with the molecular formula C17H17ClN6O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 03A5ORL08Q, chemically known as 4-methyl-1-piperazinecarboxylic acid ester with 6-(5-chloro-2-pyridyl)-6,7-dihydro-7-hydroxy-5h-pyrrolo(3,4-b)pyrazin-5-one but generally known as zopiclone, which bears US NIH Compound Identifier 5735. European Medicines Agency schedules Zopiclone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00188MIG.

UNSPSC 51362506 Zopiclone is a Commodity code that maps to pharmaceutical procurement, though the single recent state and local opportunity on file shows minimal alignment with the code's nominal scope. Seminole County, Florida posted an IFB (Solicitation Number IFB60459723LAS) on June 30, 2026 seeking to procure naloxone and drug deactivation systems — substances and equipment oriented toward overdose response and controlled-substance management rather than zopiclone, a sedative-hypnotic medication. The county sought 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Vendors were required to submit bids electronically, include all shipping and delivery costs, hold standard insurance coverage (workers' compensation, commercial general liability, and professional liability), maintain E-Verify compliance, and complete drug-free workplace certification. The contract carried an initial two-year term with a one-year renewal option and a three-month probationary period allowing Seminole County termination with or without cause.

The code shows limited recent activity under its stated pharmaceutical classification. The single posted opportunity originated from a county health department rather than a state agency, school district, or transit authority, and the mismatch between the code name (zopiclone) and the actual procurement (naloxone and drug deactivation systems) suggests the opportunity may have been miscoded at posting. The response deadline for the Seminole County IFB was July 26, 2023 — a date that predates the posting date of June 30, 2026 shown in the source record, indicating a data inconsistency. Without additional recent opportunities or corrected records showing active state and local zopiclone procurement, the code presents no clear procurement signal for business development pursuit.